Search for: "Teva Pharmaceuticals LLC"
Results 141 - 160
of 254
Sorted by Relevance
|
Sort by Date
21 Jan 2010, 1:00 am
Kremers Urban LLC et al. [read post]
16 Aug 2011, 11:35 pm
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
9 Jan 2023, 9:01 pm
Teva Pharmaceutical The $420 million settlement between Teva and investors resolves allegations that the company engaged in a generic drug price-fixing conspiracy that allowed it to drastically raise prices on generic drugs from 2013 to 2015 – as high as 1,000%. [read post]
24 Aug 2021, 2:10 am
Teva GlaxoSmithKline LLC v. [read post]
27 Jun 2011, 8:41 am
” Certiorari stage documents: Opinion below (3d Circuit) Petition for certiorari Brief in opposition Petitioners’ supplemental brief Respondents’ supplemental brief Petitioners’ reply Amicus brief of TEVA Pharmaceuticals USA, Inc. [read post]
21 Aug 2008, 9:43 pm
Following the Federal Circuit's decision in Teva Pharmaceuticals USA, Inc. v. [read post]
15 May 2023, 9:59 am
One case in which the Court denied certiorari was Teva Pharmaceuticals USA v. [read post]
15 Aug 2018, 9:26 am
Oral Arg. at 20:00–07.Both Teva and an 1859 case were cited:Imposing such arequirement would be inconsistent with the SupremeCourt’s guidance in Teva Pharmaceuticals, where theCourt held that, even in cases in which the district courtfinds a need to look beyond the patent’s intrinsic evidenceand to consult extrinsic evidence, the district court muststill conduct a legal analysis: “whether a skilled artisanwould ascribe that same meaning to that term… [read post]
2 Feb 2018, 1:31 pm
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries, Ltd., Case 2016-1284, 2016-1787 (Fed. [read post]
18 Sep 2016, 6:03 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
24 Jul 2014, 12:54 pm
District Judge Tanya Walton Pratt concluded that Defendants Teva Parenteral Medicines, Inc. of Irvine, California; APP Pharmaceuticals, LLC of Schaumburg, Illinois; Pliva Hrvatska D.O.O. of Zagreb, Croatia; Teva Pharmaceuticals USA Inc. of North Wales, Pennsylvania; and Barr Laboratories, Inc. of Montvale, New Jersey failed to prove invalidity of U.S. [read post]
30 Jan 2020, 10:49 am
Purdue Pharma and Teva Pharmaceuticals – Oklahoma – $355 million. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb)… [read post]
18 Oct 2007, 11:00 pm
Quite right, said the CFI, dismissing Intervideo's appeal - CFI decision in Case T-105/06 Intervideo v OHIM, (IPKat)EPO adds EPC post-grant data to PRS database (EPO), EU Patent Jurisdiction: Details of New Proposals From Portuguese EU Presidency (Blog@IPR::JUR), (IAM), Teva invalidates acid metabolite patents for terfenedine, (Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc, Aventis and Sepracor [2007] EWHC 2276 (Ch) ), (IPKat),… [read post]
13 Apr 2011, 5:13 pm
P. 9(b) applies to false marking cases, that did not stop Pharmaceutical Technologies, LLC (“PharmaTech”) from lodging a Complaint last week in the U.S. [read post]
27 Aug 2012, 9:31 am
" This dispute arose when Teva Parenteral Medicines, Inc., Barr Laboratories, Inc., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
27 Aug 2012, 9:31 am
" This dispute arose when Teva Parenteral Medicines, Inc., Barr Laboratories, Inc., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
11 May 2023, 1:16 pm
New Relists Teva Pharmaceuticals USA, Inc. v. [read post]
22 Dec 2010, 3:01 am
LLC et al. v. [read post]
25 May 2010, 12:51 pm
., Teva Pharmaceuticals USA, Inc., and UDL Laboratories, Inc. [read post]
